SEC Form D filing

NexGelRx, Inc., 2026-01-14

An SEC Form D private-offering notice from Langhorne, PA, a $1,250,000 filer-stated offering target in Biotech. Filed 2026-01-14. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

NexGelRx, Inc. Verified via SEC Form D

Prescription drug delivery company using hydrogel technology, spun off from NEXGEL, Inc. (NASDAQ: NXGL), based in Langhorne, PA.

Filed 2026-01-14Filed to raise $1,250,000First money in 2025-12-10Raised so far $1,250,000HQ (as filed) Langhorne, PASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Delayed filing
Source linked the Form D on EDGAR↗Named in the filing 5 executives & directors
Open this row on the live feed →More new filings in Pennsylvania →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source